Table 2.
Status After Fontan Surgery.
| Fenestration | No Fenestration | Adjusted | ||||
|---|---|---|---|---|---|---|
| Characteristics | Mean±SD/% | Median | Mean±SD/% | Median | P | P* |
| N | 361 | 175 | ||||
| Length of hospital stay (days) | 16.1±20.1 | 11.0 | 21.9±26.0 | 13.5 | <.001 | 0.05 |
| Postoperative complications (#) | 1.4±1.9 | 1.0 | 2.8±2.6 | 2.0 | <.001 | 0.3 |
| Pericardial effusion | 7% | 21% | <.001 | 0.3 | ||
| Pleural effusion | 21% | 35% | <.001 | 0.3 | ||
| Discharge medications (#) | 4±1 | 4 | 3±2 | 3 | 0.003 | 0.02 |
| Antithrombotic | 77% | 50% | <.001 | 0.02 | ||
| ACEi | 67% | 24% | <.001 | <.001 | ||
| Diuretics | 96% | 91% | 0.02 | 0.3 | ||
| POST-FONTAN | ||||||
| Catheter interventions (#) (Excluding fenestration related procedures) |
0.6±1.0 | 0.3±0.9 | 0.001 | 0.03 | ||
| Number of surgeries | 0.3±0.8 | 0.5±1.1 | 0.2 | 0.2 | ||
| Stroke | 2% | 1% | 0.5 | 0.3 | ||
| Thrombosis | 7% | 7% | 0.9 | 0.8 | ||
| PLE | 3% | 6% | 0.1 | 0.2 | ||
| Arrhythmia | 19% | 24% | 0.2 | 0.5 | ||
*
adjusted for center, year of Fontan, age at enrollment, and performance of Stage II
ACEi= angiotensin converting enzyme inhibtion, PLE= protein losing enteropathy